Previous Article | Next Article 
Journal of Clinical Microbiology, October 2001, p. 3814-3814, Vol. 39, No. 10
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.10.3814.2001
LETTERS TO THE EDITOR
Genetic Mutations Occur Gradually in In Vivo Populations of
Mycobacterium tuberculosis Bacteria
 |
LETTER |
Benjamin et al. (1) reported that two
Mycobacterium tuberculosis isolates (isolated from the same
bronchoscope 2 days apart) demonstrated distinct, but similar
IS6110 restriction fragment length polymorphism (RFLP)
patterns, as well as slightly different spoligopatterns. They
interpreted this finding as the result of a single transposition event
of IS6110 and mentioned as its possible explanation (i) that
the transposed strain was a rare constituent of the M. tuberculosis population or (ii) that adverse bacterial conditions
stimulated the transpositional event. We think these explanations
represent different angles of the same phenomenon and may be explained
by our previous observations (2).
We showed with single-colony cultures that M. tuberculosis
populations can consist of subpopulations with different
IS6110 RFLP patterns (2). The occurrence of
these mixed bacterial populations in M. tuberculosis
isolates was associated with increased patient age. Therefore, it seems
likely that, in the human body, bacterial populations change gradually
over time. That specific growing conditions play a role in the
occurrence of transpositions of IS6110 was confirmed in our
earlier study of 544 patients with serial isolates, for whom we found
that the change of IS6110 RFLP patterns of M. tuberculosis isolates was associated with extrapulmonary disease
(3).
In conclusion, mutations in populations of M. tuberculosis
bacteria, promoted by specific growing conditions, occur gradually, resulting in a different DNA fingerprinting pattern for part of a given
M. tuberculosis population compared to the predominant pattern of the larger part of that population. If a part of a population of M. tuberculosis bacteria is typed, only the
DNA fingerprinting pattern of that part of the population is revealed. This could explain why Benjamin et al. found slightly different RFLP
and spoligotype patterns for the patient isolate and the isolate of the
bronchoscope contaminant. Further experimental research is needed to
determine in how far adverse bacterial conditions, i.e., conditions
comparable to those in the bronchoscope, can stimulate transpositional events.
 |
REFERENCES |
| 1.
|
Benjamin, W. H.,
K. H. Lok,
R. Harris,
N. Brook,
L. Bond,
D. Mulcahy,
N. Robinson,
V. Pruitt,
D. P. Kirkpatrick,
M. E. Kimerling, and N. E. Dunlap.
2001.
Identification of a contaminating Mycobacterium tuberculosis strain with a transposition of an IS6110 insertion element resulting in an altered spoligotype.
J. Clin. Microbiol.
39:1092-1096[Abstract/Free Full Text].
|
| 2.
|
de Boer, A. S.,
K. Kremer,
M. W. Borgdorff,
P. E. W. de Haas,
H. Heersma, and D. van Soolingen.
2001.
Genetic heterogeneity in Mycobacterium tuberculosis isolates reflected in IS6110 restriction fragment length polymorphism patterns as low-intensity bands.
J. Clin. Microbiol.
38:4478-4484[Abstract/Free Full Text].
|
| 3.
|
de Boer, A. S.,
M. W. Borgdorff,
P. E. W. de Haas,
N. J. D. Nagelkerke,
J. D. A. van Embden, and D. van Soolingen.
1999.
Rate of change of IS6110 genotypes of Mycobacterium tuberculosis based on serial patient isolates.
J. Infect. Dis.
180:1238-1244[CrossRef][Medline].
|
| | | | |
A. S. de Boer
D. van Soolingen
National Institute of Public Health and the Environment Bilthoven, The Netherlands
|
| | | | |
M. W. Borgdorff
Royal Netherlands Tuberculosis Association The Hague, The Netherlands
|
 |
AUTHORS' REPLY |
We appreciate the comments of Drs. de Boer, Borgdorff, and van
Soolingen. We agree that our observations could be due to selection of
a rare constituent of the Mycobacterium tuberculosis
population that occurred spontaneously or as a result of the harsh
conditions within the bronchoscope.
| | | | |
Nancy E. Dunlap
William H. Benjamin Jr.
University of Alabama at Birmingham Birmingham, Alabama
|
Journal of Clinical Microbiology, October 2001, p. 3814-3814, Vol. 39, No. 10
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.10.3814.2001